Myosins are a large family of molecular motors responsible for the generation of forces and movements within eukaryotic cells. Different myosins from the 35 distinct subgroups 1 organise the actin cytoskeleton, drive cell motility, and participate in organelle & vesicle transport, cell division and signal transduction systems 2 . In mammals, the myosin IIs have two branches: one branch includes all of the striated muscle myosins IIs (at least 11 common isoforms) and the second includes both the non-muscle (three isoforms) and smooth-muscle (one gene alternately spliced to
give two isoforms) lineage 3 4 .
Striated muscles produce rapid movements of the whole organism (skeletal muscles)
or pump blood to transport nutrients and waste products between specialist organs (cardiac muscle). A key feature of muscle cells is that the speed of contraction (specifically the maximum shortening speed) is a property of the specific myosin isoform(s) expressed in the cell 5 . The contraction parameters of a muscle adjust to the size of the organism; small animals have fast contracting muscle fibers. As size increases muscle contraction becomes slower to compensate for the greater momentum and inertia associated with a larger mass 4 6 . This has been widely observed in measured heart rates that are known to be correlated with basal metabolic rate and anti-correlated with body size across a wide range of species 7 .
The rate of muscle contraction in different species can be controlled in two ways.
Firstly, muscles can express different combinations of fast and slow contracting muscle fibres (containing different myosin isoforms) to adjust contraction parameters to the physiological requirements 4 . Secondly, during evolution individual myosin isoforms may adapt to different demand including the change in species size.
Here we consider the second of these mechanisms. If the maximum velocity of contraction, driven by a myosin isoform, varies with animal size then there must be specific alterations in the sequence of the myosin to generate the altered velocity.
We have investigated evolution of the myosin-II family of proteins in mammals to identify if myosin isoforms expressed in muscle have been adapted to body mass as animals have evolved from small to larger sizes. To do this we compare a set of 12 common myosin II isoforms (Table 1 ) from 12 mammals of varying size. Nine isoforms are from striated muscle, the smooth muscle isoform and two non-muscle isoforms. The non-muscle isoforms provide a negative control, as they act at the cellular level and are therefore unlikely to be influenced by body mass.
Results
All myosin II isoforms contain a head region, or motor-domain, and a tail region. The N-terminal globular head domain (approximately 760 amino acids) contains all of the requirements for motor activity, while the C-terminal tail region (~1200 amino acids) drives dimerization and oligomerization into myosin filaments. We have considered evolution of the head and tail domains separately as the shortening speed of muscle contraction is a property of the head domain and not the tail. 12 species were selected (Table 1) , for which we had complete sequences for most of the 12 myosin II isoforms giving 130 sequences for the preliminary analysis. We excluded any sequences where sequence information was missing (see methods) as these could have affected the results obtained. We first considered evolutionary divergence by calculating the sequence identity of each pair of sequences within each isoform. The data is illustrated for three myosin isoforms in Figure 1A and the analysis for the other nine isoforms is given in the supplementary information ( Figure S1 ). Sequence identity rather than conservation was used because evolution was considered within a single myosin isoform. A low level of divergence was expected and as such even conservative changes of amino acids may be relevant to adaptation to body mass.
For the head domains eight of the 12 isoforms have a similar rate of divergence at ~0.035% per Myr ( Figure 1B ), while the β-myosin has a much higher rate of divergence (0.05% per Myr) and the embryonic and the non-muscle A and B head domains have a lower rate of divergence than average (0.01-0.02% per Myr). This is consistent with our hypothesis since a low divergence for non-muscle myosins suggests a tightly constrained sequence with little adaptive pressure. In contrast the β-myosin, which when in muscle shows the greatest dependence of velocity of contraction on species size, has the greatest rate of divergence 2.5-5 fold higher than the non-muscle myosins.
For the tail domains, the β-myosin has the lowest rate of divergence (0.017% per Myr) and the extraocular isoform has the highest rate of divergence (0.095% per Myr). The myosin 2B isoform has a similar rate of divergence in the head and tail domains and so we compared the difference in the rate of divergence to this isoform ( Figure 1B ). This shows that there is greater divergence in the tail domains, with eight of the twelve domains having rates of divergence that are significantly different to that of the 2B isoform, whereas for the head the rate of divergence is significantly different for only four of the isoforms ( Figure 1B ).
The myosin domains studied here exhibit an average divergence rate of 0.035%/Myr for the heads and 0.04%/Myr for the tails. These are at the lower end of the divergence rates reported for proteins which range from the very highly conserved histones (eg, H2 0.0025% /Myr) through cytochrome c (0.067% /Myr) to 0.27% /Myr for haemoglobin or the immunoglobulin v region (1.25%/Myr) 8 .
Comparing the ratio of head/tail sequence divergence ( Figure 1B ) many isoforms fall within the range 0.75 -1.25 indicating that the two domains have a similar rate of divergence. However, the ratio of divergence for the head and tail regions were all significantly different from one except for the smooth muscle, non-muscle 2B, slow tonic muscle and fast muscle 2B myosin isoforms. Most strikingly the β-isoform has a much faster rate of divergence in the head than the tail (ratio of 2.9) while the opposite is true of extraocular myosin (ratio 0.36, due to high rate of tail divergence), non-muscle 2A and embryonic myosin (ratio 0.21 and 0.43 respectively, due to low rates of head divergence). It has been widely thought that the myosin head and tail domains have coevolved 1, 9, 10 , however our analysis suggests that the rate of sequence divergence is not the same for the head and tail and varies for myosin II isoforms (see discussion).
Adaptation of myosin II to increasing body mass
To consider how myosin II isoforms may have evolved in adaptation to body mass, we investigated if there was a correlation between sequence divergence and body mass. Mass values were collected from the literature, and we quote the middle of the range of values reported. The range of masses cover more than six decades from 6 g to 10,000 kg (Supplementary Table 2 ). Being one of the smallest species, mouse was selected as a reference and the sequence identify of the other 11 species with the mouse sequence plotted against the species body mass ( This initial analysis used a small number of species, to ensure that the same set of species were represented in the analyses for all twelve myosin isoforms. This eliminates any internal bias from the species selected. To further establish if β-myosin has adapted to species mass we performed the same analysis for all of the available β-myosin sequences. To enable comparison with other isoforms we also expanded the analysis for the embryonic and non-muscle 2A myosin isoforms to provide a control. This added a further 27 species with a complete β-myosin sequence giving a total of 39 species. For the embryonic and the non-muscle myosin 2A 50 and 60 sequences were used respectively. Many more partial sequences were available but excluded from our analysis because the calculation of sequence divergence would not be accurate.
For this larger data set of 39 β-myosin sequences, the relationship between mass and sequence divergence of the head domain is retained (gradient -0.73 ± 0.084%
per log mass unit) with a slightly wider spread (R-value of -0.81, Figure 3 ). The analysis for the larger sets of the embryonic and non-muscle isoforms shows no mass dependence (gradient -0.091±0.053 and -0.106 ±0.060 % per log mass unit for embryonic and non-muscle myosin respectively with R = -0.22 in both cases; Figure   3 ). The data for the tail domains of all three isoforms show a small R-value of between -0.33 and -0.45 indicating no dependence on mass. The larger set of sequences enabled comparison between different evolutionary groups as the data contains species from Laurasiatheria (mostly ungulates and cetacean),
Euarchontoglires (rodents and primates) and a couple of Afrotheria or Metatheria.
The correlation between sequence divergence and body mass is maintained for these groups ( Figure 3 ).
Location of sequence changes in the β-myosin
Since the sequence changes observed in each domain are relatively small (not exceeding 8%), it is of interest to examine where these sequence changes are The one exception is converter residue Gly-747 which is replaced in 7 species by Ser.
Complete analysis of the sequence changes and their possible functional significance is beyond the scope of the current work but the type of issues raised by this analysis can be illustrated by consideration of Loop1. This is a surface loop near the entrance to the nucleotide-binding site and is a region that is hypervariable in both length and sequence between myosin classes and has been associated with controlling ADP release from myosin 12, 13 In the β-myosin tail, there are very few changes, only four sites have more than two alternate residues, and ~30 sites have two alternate residues. The sites in which five or more species have a change in the residue are numbered in In the other two myosins there are very few changes in sequence in the heads and those that stand out against the background are numbered in Figure 4 . Very few of these have more than a single alternate amino acid. The sequence changes in the tail are much more common and are too frequent to pick out any specific details.
The large variation in the rates of myosin tail sequence divergence was not expected. Most myosin tails studied here have divergence rates of between 0.03 to 0.05% per Myr but β-myosin has an unusually low rate (0.017% per Myr) while the extraocular myosin has a rate of at least twice that of any other myosin (0.094% per Myr). Myosin II tails might be expected to be well-conserved since they require a strict seven amino acid repeat pattern to form the coiled-coil dimer, they must pack closely together in groups (both parallel and antiparallel packing) via multiple interactions to form the thick filament which may be composed of a single myosin isoform, or different isoforms. In addition, the myosin in the thick filament of the sarcomere has a large set of additional binding partners including titin, myosin binding protein C and M-line proteins. This set of interactions might be expected to limit the divergence of the tail region but they appear to cover a similar range to that of the motor domain. The observation that the tail sequences may not all diverge at the same rate was perhaps unsurprising but such a large variation was not anticipated. At present we have no simple explanation for the distinct rates of divergence of the β and extraocular myosin tails.
Discussion
Our analysis of myosin evolution has identified two central findings: first that head and tail domains of certain myosin isoforms have not co-evolved at the same rates and secondly that sequence divergence of the β-myosin head domain is correlated with body mass indicating that the domain has evolved in adaptation to increasing body mass.
Previous studies have observed that across the wider myosin family the head and tail sequences are tightly coupled throughout evolution 9, 10 . Particularly, Korn concluded that the myosin heads and tails have co-evolved since sequence analysis of the heads or tails resulted in the same pattern of evolution and the same assignment of myosins into subgroups. More recent analyses with increasing numbers of sequences have reached the same conclusion 1, 3, 16 . A study of the human myosin II sequences revealed almost identical degrees of divergence between the heads and tails of different isoforms 17 . Contrary to this study in a single species, we observed that myosin II isoforms can show distinct rates of divergence for their head and tail domains across a range of mammals. This is most clearly seen in the non-muscle 2a and extraocular myosins where the tail domains diverge at 3-4 times the rate that of the head domain, and in contrast in the β-myosin where the head diverges three times faster than the tail.
The high rate of β-myosin head domain divergence can be explained in the context of the adaptation to increasing body mass. The head domain directly controls muscle contraction velocity and the adaptation to changes in body mass occurred via variation in the head domain. Such variation did not occur in the tail domain because it has a different functional role that is not directly relevant to speed of muscle contraction. In current views of muscle contraction the maximum shortening velocity (Vo) is related to the working stroke (d) of the myosin (head and neck) and the time (τ) during each ATP turnover for which the myosin remains attached to its site on the actin filament 18 .
The working stroke has been estimated for a number of myosin II isoforms and is thought to be relatively invariant whilst т does alter in parallel with changes to Vo 19 20 . It is well established for the slow β-myosin isoform that the lifetime of the attached cross bridge is limited by the time required for ADP release after the working stroke (1/k -ADP ). k -ADP has been measured for a number of purified β-myosin isoforms in vitro and the measured value predicts the measured Vo for a muscle contraction with high precision (see supplementary Figure 2 ).
Our investigation of adaptation to increasing body mass during evolution only identified a strong correlation for the β-myosin head domain. We propose that the variation identified in this domain is required to optimize the myosin for the required contraction velocity/heart rate. In the head domain we observed a 0.73% change in sequence per 10 fold change in mass. For a motor domain of 780 amino acids this translates to ~6 amino acids for each 10 fold change in mammal mass. Rat and human differ in mass by 230 fold (0.3 -70 kg) and have 32 differences in the sequence of the β-myosin head. This pair of species is a useful comparator since the physiology of the heart and of slow skeletal muscle expressing this isoform and the protein biochemistry of the β-myosin has been studied in detail.
We suggest that three muscle contraction parameters are linked to changes in body mass and are therefore driven by the sequence changes in β-myosin; heart rate, muscle fibre maximum shortening velocity (Vo), and the rate constant limiting ADP release from the actin.myosin complex (k-ADP ). The heart rate, Vo and k -ADP each change 3-5 fold between rat and man when measured under the same conditions. parameters (including velocity) of a skeletal muscle can be adapted by adjusting the mix of fiber types (and hence myosin isoforms) used in a specific muscle. Thus, the selective pressure on a specific myosin isoform in skeletal muscle may be different in each mammal. The β-cardiac/slow muscle myosin is unusual in that there is only a single major slow isoform and therefore there is little scope to adjust the contraction parameters by mixing fibre types. Fast muscle expresses a combination of two or three fast isoforms in addition to some slow isoform and specialist isoforms. Data on detailed biomechanics on contraction of muscles fibres expressing a single myosin isoform are rarely available, making any detailed assessment of selective pressure difficult. The heart and slow muscle fibres, in contrast, are relatively similar in function across mammals and the simple relationship between heart rate and size is well established. Only two myosin isoforms are expressed to any significant extent in the heart α and β and only in the smallest mammals does α-cardiac myosin replace β in the heart ventricle (the β myosin is however used in slow twitch muscle even in small mammals such as the mouse). This may therefore allow the size-sequence divergence relationship to be more easily defined.
In summary, we present evidence that the head and tail domains of some myosin isoforms have evolved at different rates and that these differences in divergence are likely to relate to specialised function. This is highlighted by the correlation of β-myosin sequence divergence with body mass, which we propose is required to fine tune the heart rate of the species.
Materials and Methods
Protein sequences were extracted from RefSeq 29 and Uniprot 30 as listed in Supplementary Tables 1 & 2 . Sequences were selected either as canonical, well annotated isoforms (e.g. human MyHC7 Uniprot:P12883), or by using BLAST 31 to search for homologues of the human myosin proteins within the genomes of the other mammals. To ensure that each sequence corresponded to the requisite specific isoform, each sequence identified initially by database annotation or by BLAST, was further analysed using BLAST to compare it to UniProt to ensure that the sequence was complete and that it was most closely similar to the canonical standard for that isoform. Incomplete sequences were excluded from our analysis because sequence gaps could have a major effect on the sequence comparison for such closely related isoforms.
For each isoform, the protein sequences were divided into the Head (1-778, β-myosin numbering) and Tail (779 -1938) regions. For each region of each myosin, the sequences were aligned using Clustal Omega 32 ; the resulting multiple sequence alignment was used to construct a percentage identity matrix between the species.
Sequence identity was used rather than sequence similarity as we are considering small changes (>93% identity, >98% similarity) within the isoform and substitutions that would normally be classed as similar (e.g. aspartate to glutamate) may be relevant. A 2-fold change in a rate constant that controls, for example shortening velocity, requires only a change of the order of 1 kcal/mol in the activation energy according to transition state theory. This is comparable to a single H-bond or van der Waals interaction. Neighbour joining trees were also generated using Clustal Omega, with the opossum sequences set as the outgroup.
An evolutionary distance matrix was generated using evolutionary distances extracted from TimeTree 33 ).
The masses of each species were extracted from a wide range of information sources and are listed in the Supplementary Information Tables 1 & 2 . To compare sequence divergence against either evolutionary time or animal body mass, the relevant matrices were plotted against each other.
The rates of evolutionary divergence for each myosin domain were calculated from graphs of the sequence identity versus evolutionary distance using a linear model of regression fitted using unweighted least squares with the regression line passing through the origin (i.e. 100% sequence identity at an evolutionary distance of zero).
To test for a difference in slope between the Head and Tail domains for each myosin isoform, the test statistic used was Data Fig S1) shown separately for the Head and Tail segments and the ratio (head/tail) of the two. The dashed line represents the value for myosin 2B which is close to the means of all values in both Head and Tail plots. Values that differ from the myosin 2b value at the >95% (*) and >99% (**) significance level, based on z-scores (see Methods), are indicated. The dotted line in the ratio plot represents the value of 1 when both slopes are the same. Stars indicate the value is significantly different to one (* >95%; ** >99%). The double-headed arrows indicate the set of adult sarcomeric myosins. Figure 3 The dependence of sequence identity on species mass for three myosin heavy chains. Percent sequence identity to the mouse sequence for three myosins as a function of species mass Details of the species mass and sequences used are given in Table  S2 . The data uses all complete sequences present in the data base in September 2015 and includes 59 MyHC3, 39 MyHC7and 60 MyHC9 sequences. Open circle are Laurasiatheria, filled squares are Euarchontoglires and half-filled triangles are Afrotheria or Metatheria. The regression lines are shown with the correlation coefficient R and the slopes in units of % identity/log mass unit. 
Tables and Figures

